Literature DB >> 27698246

Optimization Strategies for the CRISPR-Cas9 Genome-Editing System.

Charles E Vejnar1, Miguel A Moreno-Mateos1, Daniel Cifuentes1, Ariel A Bazzini1, Antonio J Giraldez2.   

Abstract

The CRISPR-Cas9 system uncovered in bacteria has emerged as a powerful genome-editing technology in eukaryotic cells. It consists of two components-a single guide RNA (sgRNA) that directs the Cas9 endonuclease to a complementary DNA target site. Efficient targeting of individual genes requires highly active sgRNAs. Recent efforts have made significant progress in understanding the sequence features that increase sgRNA activity. In this introduction, we highlight advancements in the field of CRISPR-Cas9 targeting and discuss our web tool CRISPRscan, which predicts the targeting activity of sgRNAs and improves the efficiency of the CRISPR-Cas9 system for in vivo genome engineering.
© 2016 Cold Spring Harbor Laboratory Press.

Mesh:

Substances:

Year:  2016        PMID: 27698246     DOI: 10.1101/pdb.top090894

Source DB:  PubMed          Journal:  Cold Spring Harb Protoc        ISSN: 1559-6095


  3 in total

Review 1.  Functional interrogation of non-coding DNA through CRISPR genome editing.

Authors:  Matthew C Canver; Daniel E Bauer; Stuart H Orkin
Journal:  Methods       Date:  2017-03-10       Impact factor: 3.608

2.  New pathogenic variants in COQ4 cause ataxia and neurodevelopmental disorder without detectable CoQ10 deficiency in muscle or skin fibroblasts.

Authors:  Serena Mero; Leonardo Salviati; Vincenzo Leuzzi; Anna Rubegni; Cristina Calderan; Francesca Nardecchia; Daniele Galatolo; Maria Andrea Desbats; Valentina Naef; Federica Gemignani; Maria Novelli; Alessandra Tessa; Roberta Battini; Filippo M Santorelli; Maria Marchese
Journal:  J Neurol       Date:  2021-03-11       Impact factor: 4.849

3.  Modification of improved-genome editing via oviductal nucleic acids delivery (i-GONAD)-mediated knock-in in rats.

Authors:  Takuya Aoshima; Yukari Kobayashi; Hisayoshi Takagi; Kenta Iijima; Masahiro Sato; Shuji Takabayashi
Journal:  BMC Biotechnol       Date:  2021-11-01       Impact factor: 2.563

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.